Engineered human myocardium (iPSC-derived) biological ventricular assist tissue
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Engineered human myocardium (iPSC-derived) biological ventricular assist tissue, covering 2026-02-20 to 2026-02-20. Get the full timeline:
Most recent: Clinical Trial Update: Safety and Efficacy of Induced Pluripotent Stem Cell-derived Engineered Human Myocardium as Biological Ventricular Assist Tissue in Terminal Heart Failure [Phase 1, Phase 2]